Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.
|Number of pages||20|
|Publication status||Published - 29 Apr 2021|
|Event||Westminster Health Forum policy conference: Priorities for biosimilars in the NHS - development, regulation, commissioning and improving engagement - Held Online|
Duration: 29 Apr 2021 → 29 Apr 2021
|Conference||Westminster Health Forum policy conference|
|Period||29/04/21 → 29/04/21|